Tag : risk

Decentralized trials (DCTs) at Risk, or Ready?

It should come as little surprise that the rise in decentralized trials (DCTs) and increase in study complexities have magnified performance demands across clinical trial teams. A recent survey by Ernst & Young found 50% of clinical trials will be hybrid or decentralized by 2024. This is welcome news for sponsors

Posted on 1 Mar 2022
By ArcheMedX Team
In Clinical Research Blog

One Key Approach to Reducing Risk in Clinical Operations

There are many ways a clinical trial can go wrong: There might be delays in site identification, initiation, or patient enrollment. There could be high initial screen failure rates or improperly enrolled subjects. Procedural errors like those related to randomization, dosing, or clinical test implementation might occur.

Posted on 12 Mar 2020
By Kelly Ritch
In Clinical Research Blog

Evaluating Risk: Is Your Staff Clinical Trial Ready?

Your trial is about to go live – and given the months (or years) that have gone into planning, site selection, and site start-up – you pause to ask yourself whether your sites or staff are ready?